Tome Biosciences
@Tome_bio
ID:1457712856435200006
08-11-2021 14:13:31
32 Tweets
350 Followers
1 Following
#NationalDNADay honors the Human Genome Project's completion in 2003 and DNA's double helix discovery in 1953. These milestones laid Tome's foundation and inspired our mission of curing patients through cell and integrative gene therapies.
#DNA #genomeediting
Gene editing is no longer science fiction. It's science fact.
In this article by The Wall Street Journal, learn about the stories behind people who have received gene editing treatments and how this transformative technology is changing their lives.
#GeneEditing
on.wsj.com/4a4YKDw
Programmable genomic integration (PGI) is key to everything we do at Tome.
PGI is the ability to insert any genetic sequence with site-specific precision in the genome.
bit.ly/3vydOuA
#GeneEditing
The Tome team is hitting the court for the 2024 Special Olympics Summer Games Bio-Ball tournament!
Please consider donating to Tome’s team to support Special Olympics MA mission of fostering inclusion, fun, community, and comradery.
bit.ly/3W2jFCW
We're honored to be on Boston Business Journal's list of Top 20 Best Places to Work in the medium-sized company category! A huge THANK YOU to all of our Tome-mates for making Tome such a great place to work. bizjournals.com/boston/news/20…
Curious about #CRISPR technology?
CRISPR-based systems are moving lightning-fast, but this review from Nature Reviews Molecular Cell Biology can bring you up to speed.
Explore technological advancements, strengths and weaknesses, and the potential impact on human health.
go.nature.com/430sheV
It’s #CelebrateScientistsDay , and today, we recognize the brilliant minds who have dedicated their lives to science. From groundbreaking discoveries to new technological advancements, thank you to all the scientists who have made our world a better place!
How can we ensure CRISPR-based cures can reach patients with the rarest of rare diseases?
We applaud the plan by Innovative Genomics Institute to tackle diseases untouched to date by biopharma companies.
Learn about their approach in this article from STAT:
statnews.com/2024/01/09/dou…
#CRISPR
Happy #EmployeeAppreciationDay !
As a small token of appreciation, we hosted a breakfast for our employees to honor their commitment and hard work.
With their insightful ideas and unwavering commitment, our team is the driving force behind our success.
#RareDiseaseDay is a time of unity and support for individuals & families living with rare diseases.
With the help of technology, like PGI, we can impact the rare disease community. Let's all work together to improve the lives of those affected.
#RareDiseases #GeneEditing
Tome’s CEO, Rahul Kakkar, sat down with Theral Timpson of mendelspod to discuss how genomic-based therapies are crucial in curing diseases versus treating them.
bit.ly/42HeUjC
#CRISPR #genomeediting #TomeBio #genomicmedicine
Happy #InternationalDayOfWomenAndGirlsInScience !
Women profoundly impact research and innovation and are invaluable as we pursue cures for a lifetime. Today, we’re highlighting a few of our very own who are paving the way for a more inclusive and diverse future.
#WomenInSTEM
The FDA recently approved Casgevy, a CRISPR therapeutic for beta-thalassemia. Congrats to Vertex Pharmaceuticals and CRISPR Therapeutics on this important milestone in genomic editing treatments.
bit.ly/499gEUO
#CRISPR